Pettenuzzo Greta, Ditonno Francesco, Cannoletta Donato, Pacini Matteo, Morgantini Luca, Sauer Ruben Calvo, Torres-Anguiano Juan R, Montorsi Francesco, Briganti Alberto, Bartoletti Riccardo, Veccia Alessandro, Bertolo Riccardo, Antonelli Alessandro, Crivellaro Simone
Department of Urology, University of Illinois at Chicago, Chicago, IL, USA.
Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Eur Urol Open Sci. 2024 Aug 12;67:69-76. doi: 10.1016/j.euros.2024.07.110. eCollection 2024 Sep.
The role of pelvic lymph node dissection (PLND) for prostate cancer is still controversial. This study aims to compare the outcomes of PLND between extraperitoneal single-port (SP eRARP) and transperitoneal multiport (MP tRARP) robotic-assisted radical prostatectomy.
This was a retrospective analysis from our single-center database for patients who underwent SP eRARP or MP tRARP with PLND between 2015 and 2023. The primary endpoint was to analyze and compare specific data related to PLND between the two populations by the detection of pN+ patients, the total number of lymph nodes removed, and the number of positive lymph nodes removed. The secondary endpoints included comparing major complications, lymphoceles, and biochemical recurrence between the two cohorts of the study.
A total of 293 patients were included, with 85 (29%) undergoing SP eRARP and 208 (71%) undergoing MP tRARP. SP eRARP showed significant differences in PLND extension from MP tRARP, while MP tRARP yielded more lymph nodes ( < 0.001). There were no differences in pN+ patient detection ( = 0.7) or the number of positive lymph nodes retrieved ( = 0.6). The rates of major complications ( = 0.6), lymphoceles ( = 0.2), and biochemical recurrence ( = 0.9) were similar between the two groups. Additionally, SP eRARP had shorter operative time ( = 0.045), hospital stay ( < 0.001), and less postoperative pain at discharge ( = 0.03). Limitations include a retrospective, single-center analysis.
Despite the SP approach in RARP resulting in fewer retrieved lymph nodes, outcomes were comparable with the MP approach regarding the detection of patients with positive lymph nodes and the number of positive nodes. Additionally, the SP approach led to lower pain levels and shorter hospital stays.
With this study, we demonstrate that pelvic lymph node dissection performed via the extraperitoneal approach during robotic-assisted radical prostatectomy with a single-port system provides comparable outcomes with the standard transperitoneal multiport approach in detecting patients with positive lymph nodes and retrieving positive nodes. In addition, it offers significantly reduced pain levels and shorter hospital stays.
盆腔淋巴结清扫术(PLND)在前列腺癌治疗中的作用仍存在争议。本研究旨在比较腹膜外单孔(SP eRARP)与经腹多孔(MP tRARP)机器人辅助根治性前列腺切除术中PLND的效果。
这是一项对2015年至2023年间在本单中心数据库中接受SP eRARP或MP tRARP联合PLND治疗的患者进行的回顾性分析。主要终点是通过检测pN+患者、切除的淋巴结总数以及切除的阳性淋巴结数量,分析并比较两组人群与PLND相关的具体数据。次要终点包括比较两组研究对象的主要并发症、淋巴囊肿和生化复发情况。
共纳入293例患者,其中85例(29%)接受SP eRARP,208例(71%)接受MP tRARP。SP eRARP在PLND范围上与MP tRARP存在显著差异,而MP tRARP切除的淋巴结更多(<0.001)。在pN+患者检测(=0.7)或切除的阳性淋巴结数量(=0.6)方面无差异。两组之间的主要并发症发生率(=0.6)、淋巴囊肿发生率(=0.2)和生化复发率(=0.9)相似。此外,SP eRARP的手术时间更短(=0.045)、住院时间更短(<0.001),出院时的术后疼痛更轻(=0.03)。局限性包括回顾性单中心分析。
尽管RARP中的SP方法切除的淋巴结较少,但在检测阳性淋巴结患者和阳性淋巴结数量方面,其结果与MP方法相当。此外,SP方法导致疼痛程度更低、住院时间更短。
通过本研究,我们证明在机器人辅助根治性前列腺切除术中,使用单孔系统经腹膜外途径进行盆腔淋巴结清扫术,在检测阳性淋巴结患者和获取阳性淋巴结方面,与标准经腹多孔方法具有相当的效果。此外,它能显著减轻疼痛程度,缩短住院时间。